Colchicine for steroid-resistant recurrent pericarditis in a child

Recurrent pericarditis is rare in children and is considered idiopathic in most cases. Its course is chronic, and preventing recurrences is important for the patient’s quality of life. Although a treatment strategy in pediatric recurrent pericarditis has not yet been established, non-steroidal anti-...

Full description

Bibliographic Details
Main Authors: Ju Hee Shin, Dong Hyun Lee, Hee Joung Choi
Format: Article
Language:English
Published: Yeungnam University College of Medicine 2018-12-01
Series:Yeungnam University Journal of Medicine
Subjects:
Online Access:http://yujm.yu.ac.kr/upload/pdf/yujm-2018-35-2-222.pdf
Description
Summary:Recurrent pericarditis is rare in children and is considered idiopathic in most cases. Its course is chronic, and preventing recurrences is important for the patient’s quality of life. Although a treatment strategy in pediatric recurrent pericarditis has not yet been established, non-steroidal anti-inflammatory drugs (NSAIDs) are the most common treatment for management of this condition, followed by corticosteroids, colchicine, immunosuppressive agents, immunoglobulins, and interleukin-1β receptor antagonists (e.g. anakinra). Herein, we report a case of recurrent pericarditis with pericardial effusion in a 5-year-old child who presented with fever and epigastric pain. He responded poorly to NSAIDs and corticosteroid therapy, but was successfully treated with colchicine.
ISSN:2384-0293